HPGC Renmintongtai Pharmaceutical Corp (600829) — Cash Flow Quality Index
HPGC Renmintongtai Pharmaceutical Corp (600829) has a Cash Flow Quality Index of -4.77x as of September 2025. Operating cash flow of CN¥-187.38 Million is below net income of CN¥39.30 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of HPGC Renmintongtai Pharmaceutical Corp to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
HPGC Renmintongtai Pharmaceutical Corp Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for HPGC Renmintongtai Pharmaceutical Corp across 27 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check HPGC Renmintongtai Pharmaceutical Corp cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for HPGC Renmintongtai Pharmaceutical Corp (1998–2025)
Year-by-year earnings quality comparison for HPGC Renmintongtai Pharmaceutical Corp. For live market cap and the full company financial profile, see HPGC Renmintongtai Pharmaceutical Corp (600829) total market value.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.24x | CN¥299.98 Million | CN¥133.84 Million | ▲ +314.1% |
| 2024 | 0.54x | CN¥115.44 Million | CN¥213.27 Million | ▼ -52.5% |
| 2023 | 1.14x | CN¥332.99 Million | CN¥292.16 Million | ▼ -2.3% |
| 2022 | 1.17x | CN¥307.33 Million | CN¥263.41 Million | ▲ +238.5% |
| 2021 | -0.84x | CN¥-233.00 Million | CN¥276.51 Million | ▼ -1224.5% |
| 2020 | -0.06x | CN¥-9.22 Million | CN¥144.96 Million | ▲ +95.9% |
| 2019 | -1.54x | CN¥-411.60 Million | CN¥267.30 Million | ▼ -208.4% |
| 2018 | 1.42x | CN¥366.45 Million | CN¥257.85 Million | ▲ +159.8% |
| 2017 | 0.55x | CN¥139.07 Million | CN¥254.20 Million | ▲ +167.0% |
| 2016 | 0.20x | CN¥46.01 Million | CN¥224.51 Million | ▼ -91.9% |
| 2015 | 2.52x | CN¥333.99 Million | CN¥132.54 Million | ▼ -83.2% |
| 2014 | 14.97x | CN¥392.58 Million | CN¥26.23 Million | ▲ +2287.9% |
| 2012 | 0.63x | CN¥221.57 Million | CN¥353.49 Million | ▲ +324.8% |
| 2011 | -0.28x | CN¥-108.30 Million | CN¥388.48 Million | ▼ -158.0% |
| 2010 | 0.48x | CN¥162.99 Million | CN¥339.38 Million | ▼ -68.5% |
| 2009 | 1.53x | CN¥447.82 Million | CN¥293.52 Million | ▲ +749.5% |
| 2008 | -0.23x | CN¥-65.93 Million | CN¥280.68 Million | ▼ -133.4% |
| 2007 | 0.70x | CN¥191.10 Million | CN¥271.83 Million | ▼ -20.8% |
| 2006 | 0.89x | CN¥191.13 Million | CN¥215.32 Million | ▼ -43.3% |
| 2005 | 1.57x | CN¥313.04 Million | CN¥199.80 Million | ▲ +4.8% |
| 2004 | 1.50x | CN¥60.69 Million | CN¥40.59 Million | ▼ -62.9% |
| 2003 | 4.03x | CN¥71.65 Million | CN¥17.79 Million | ▼ -68.1% |
| 2002 | 12.61x | CN¥127.49 Million | CN¥10.11 Million | ▲ +3668.1% |
| 2001 | 0.33x | CN¥14.79 Million | CN¥44.21 Million | ▼ -66.7% |
| 2000 | 1.01x | CN¥61.85 Million | CN¥61.54 Million | ▼ -96.0% |
| 1999 | 25.06x | CN¥58.21 Million | CN¥2.32 Million | ▼ -52.3% |
| 1998 | 52.50x | CN¥41.00 Million | CN¥780.86K | — |